Aileron Therapeutics (ALRN) Tops Q1 EPS by 16c
Tweet
Share
E-mailGet Alerts alrn Hot Sheet
Join SI Premium – FREE
Aileron Therapeutics (NASDAQ: ALRN) reported Q1 EPS of ($0.86), $0.16 better than the analyst estimate of ($1.02).
For earnings history and earnings-related data on Aileron Therapeutics (alrn) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Citrini flags overheating concerns as leverage, chip rally weigh on KOSPI
- Worthington Enterprises raises dividend 5%, adds board member
- RBC initiates GE HealthCare as it sees AI-led innovation cycle driving growth
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
